What is the role of high-dose chemotherapy with autologous bone marrow or stem cell transplantation in the treatment of mantle cell lymphoma (MCL)?

Updated: Mar 15, 2019
  • Author: Muhammad Rashid Abbasi, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Answer

High-dose chemotherapy with autologous bone marrow or stem cell transplantation has not proved curative for MCL when used as second-line therapy. [32] Long-term survival data are currently unavailable in the setting of high-dose chemotherapy applied as consolidation therapy to patients in first complete remission. [33]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!